Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
12/10/2009 | US20090306348 Antibody Formulation |
12/10/2009 | US20090306347 Antibody produced using ostrich and method for production thereof |
12/10/2009 | US20090306342 Binding of molecules |
12/10/2009 | US20090306193 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer |
12/10/2009 | US20090306192 BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death |
12/10/2009 | US20090306000 Tanaproget derivatives, metabolites, and uses thereof |
12/10/2009 | US20090305991 33 Human Secreted Proteins |
12/10/2009 | US20090305971 Nogo-B Receptor |
12/10/2009 | US20090305968 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
12/10/2009 | US20090305949 Glycosylated specificity exchanger |
12/10/2009 | US20090305437 Fabrication of inorganic materials using templates with labile linkage |
12/10/2009 | US20090305434 Method of diagnosing neurophsychiatric diseases, eating disorders or metabolic diseases |
12/10/2009 | US20090305433 Water-Soluble Rhodamine Dye Conjugates |
12/10/2009 | US20090305420 Srsv detection kit |
12/10/2009 | US20090305411 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
12/10/2009 | US20090305410 Fluorescent compounds |
12/10/2009 | US20090305403 Isolation and Differentiation of Adult Hippocampal Arctic Squirrel Neural Stem Cells |
12/10/2009 | US20090305400 Modified chaperonin 10 |
12/10/2009 | US20090305384 Class II Human Histone Deacetylases, and Uses Related Thereto |
12/10/2009 | US20090305350 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
12/10/2009 | US20090305341 HCL-K1 Polypeptide Which Offers Collectin Activity |
12/10/2009 | US20090305308 Method for identifying cell-specific protein combination patterns |
12/10/2009 | US20090305297 Tyrosine phosphorylation sites |
12/10/2009 | US20090305275 DNAs AND PROTEINS OR PEPTIDES SPECIFIC TO BACTERIA OF THE SPECIES NEISSERIA MENINGITIDIS, PROCESS FOR OBTAINING THEM AND THEIR BIOLOGICAL USES |
12/10/2009 | US20090305270 Antigenic surface structure of sperm cells associated with the y chromosome |
12/10/2009 | US20090305255 Substrate Protein for M-Phase Kinase and use Thereof |
12/10/2009 | US20090304781 Master gene of arteriogenesis |
12/10/2009 | US20090304736 Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera |
12/10/2009 | US20090304728 Tem8 gene, expression forms and diagnostic and therapeutic uses thereof |
12/10/2009 | US20090304722 Chlamydia trachomatis antigens for vaccine and diagnostic use |
12/10/2009 | US20090304721 Toxin conjugated eph receptor antibodies |
12/10/2009 | US20090304719 Activatable binding polypeptides and methods of identification and use thereof |
12/10/2009 | US20090304718 Antibody Molecules Specific for Fibroblast Activation Protein and Immunoconjugates Containing Them |
12/10/2009 | US20090304717 Immuno-RNA-Constructs |
12/10/2009 | US20090304716 Treatment of metastatic breast cancer |
12/10/2009 | US20090304715 Modified antibodies with enhanced biological activities |
12/10/2009 | US20090304713 Binding agents |
12/10/2009 | US20090304710 Novel anti-cd38 antibodies for the treatment of cancer |
12/10/2009 | US20090304709 Modulators of p-selectin glycoprotein ligand 1 |
12/10/2009 | US20090304707 Monoclonal antibodies to basic fibroblast growth factor |
12/10/2009 | US20090304703 Compositions and methods for the diagnosis and treatment of immune disorders |
12/10/2009 | US20090304702 Gene expressed in prostate cancer and methods of use |
12/10/2009 | US20090304701 Antibodies binding il-1 related polypeptides |
12/10/2009 | US20090304700 Conformation specific antibodies that bind trefoil factors |
12/10/2009 | US20090304698 Modulation of ovulation |
12/10/2009 | US20090304696 Single Chain FC Polypeptides |
12/10/2009 | US20090304695 Methods for treating cancer by inhibiting wnt signaling |
12/10/2009 | US20090304693 Dual Variable Domain Immunoglobulins and Uses Thereof |
12/10/2009 | US20090304691 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof |
12/10/2009 | US20090304690 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity |
12/10/2009 | US20090304689 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
12/10/2009 | US20090304685 Anti-Factor Xlla Therapy |
12/10/2009 | US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein |
12/10/2009 | US20090304682 Multiple-variable dose regimen for treating TNFa-related disorders |
12/10/2009 | US20090304675 Method of modulation of mullerian inhibitory substance (mis) receptor for the treatment of neurodegenerative diseases |
12/10/2009 | US20090304590 Therapeutic compositions and methods |
12/10/2009 | US20090304583 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
12/10/2009 | US20090304580 Anti-Pancreatic Cancer Antibodies |
12/10/2009 | US20090304579 Cancerous Disease Modifying Antibodies |
12/10/2009 | US20090304578 Cancerous Disease Modifying Antibodies |
12/10/2009 | US20090304577 Peptides for Treatment and Diagnosis of Autoimmune Disease |
12/10/2009 | US20090303461 Detection of enhanced multiplex signals by surface enhanced raman spectroscopy (sers) |
12/10/2009 | CA2728772A1 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells |
12/10/2009 | CA2727171A1 Methods for the treatment of rheumatoid arthritis |
12/10/2009 | CA2726652A1 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
12/10/2009 | CA2726511A1 Anti-inflammatory agents |
12/10/2009 | CA2726345A1 Interleukin-1 alpha abs and methods of use |
12/10/2009 | CA2725666A1 Dual variable domain immunoglobulins and uses thereof |
12/09/2009 | EP2131199A1 Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof |
12/09/2009 | EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
12/09/2009 | EP2130840A1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof |
12/09/2009 | EP2130552A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
12/09/2009 | EP2130049A1 Cartilage intermediate layer protein 2 c1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions |
12/09/2009 | EP2129799A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
12/09/2009 | EP2129773A2 Therapeutic applications of activation of human antigen-presenting cells through dectin-1 |
12/09/2009 | EP2129691A1 Monoclonal anti-cxcl13 antibodies |
12/09/2009 | EP2129690A1 Engineered anti-tslp antibody |
12/09/2009 | EP2129688A2 Compositions and methods for detecting cancers in a subject |
12/09/2009 | EP1732648B1 Treatment of diseases |
12/09/2009 | EP1694707B1 Human anti-idiotypic antibody fragments that mimic her-2/neu |
12/09/2009 | EP1651264B1 Subunit vaccine against respiratory syncytial virus infection |
12/09/2009 | EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof |
12/09/2009 | CN101600732A MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease |
12/09/2009 | CN101600728A Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
12/09/2009 | CN101600457A Anti-IL-13 antibody formulations and uses thereof |
12/09/2009 | CN101600456A Methods and compositions for treating and monitoring treatment of IL-13-associated disorders |
12/09/2009 | CN101597596A Anti-palytoxin (PTX) monoclonal antibody, regent box thereof, and hybridoma cell line generating same and application thereof |
12/09/2009 | CN101597595A Bi-functional monoclonal antibody capable of anti-human von willbrand factor-A3 |
12/09/2009 | CN101597334A Monoclonal antibody of bluetongue virus (BTV) and preparation method and application thereof |
12/09/2009 | CN101597333A Monoclonal antibody of epizootic hemorrhagic disease virus of deer (EHDV) and preparation method and application thereof |
12/09/2009 | CN101597331A Salbutamol artificial antigen and preparation method and application thereof |
12/09/2009 | CN101597267A Melamine hapten, antigen and preparation method and applications thereof |
12/09/2009 | CN101597266A Synthesis of nickel-ion artificial antigen chelant and preparation of nickel monoclonal antibody |
12/09/2009 | CN101597233A Methamphetamine monoclonal antibody kit having no cross-reactions with ephedrine and pseudoephedrine |
12/09/2009 | CN100567324C Microcystin monoclonal antibody and its preparation method and application |
12/09/2009 | CN100567323C Preparation of testis specific protein 50 monoclonal antibody and polyclonal antibody and use |
12/09/2009 | CN100567321C Oxidoreductase from pichia capsulata |
12/08/2009 | US7630836 Polynucleotides |
12/08/2009 | US7629453 NF-κB activating gene |
12/08/2009 | US7629441 Feline interferon-alpha proteins |